Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2020-02-08 2020-02-07
Drug Identification Number 02275031 02275031
Brand name TEVA-VENLAFAXINE XR TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR 75MG CAPS VENLAFAXINE XR 75MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VENLAFAXINE VENLAFAXINE
Strength(s) 75MG 75MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100's & 500's 100's & 500's
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-02-07 2020-02-07
Remaining supply date 2020-02-07 2020-02-07
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Transitioned to the ACT Product Transitioned to the ACT Product
Health Canada comments